FDA adcomm votes in favor of Alnylam’s new indication for Onpattro – Endpoints
FDA adcomm votes in favor of Alnylam's new indication for Onpattro Endpoints NewsAlnylam Stock Trading Halted Today; FDA Advisory Committee to Review Supplemental New Drug Application for Patisiran for the Treatment of the…